Table 2.
Diagnostic sensitivities of the four serological tests investigated, referring individually to groups A to F, and overall sensitivities for all 91 AE patients including included in groups A to E (shown in bold/italic), or all 101 AE patients included in groups A to F (shown in bold/italic), respectively [CI95%].
| group (n) | EgHF-ELISA (%) | Em2-ELISA (%) | recEm18-ELISA (%) | Em-Immunoblot (%) |
|---|---|---|---|---|
| A (n = 45) | 96 [84–99] |
84 [71–94] |
73 [58–85] |
98 [88–100] |
| B (n = 11) | 91 [59–100] |
100 [71–100] |
91 [59–100] |
100 [71–100] |
| C (n = 20) | 100 [83–100] |
90 [68–99] |
90 [68–99] |
100 [83–100] |
| D (n = 11) | 82 [48–98] |
64 [631–89] |
73 [39–94] |
82 [48–98] |
| E (n = 4) | 4/4 [40–100] |
4/4 [40–100] |
4/4 [40–100] |
4/4 [40–100] |
| A-E (n = 91) | 95 | 86 | 80 | 98 |
| F (n = 10) | 30 (7–65) |
30 [7–65] |
0 [0−32] |
100 [70–100] |
| A-F (n = 101) | 88 | 80 | 72 | 98 |